Pilot Services

Targeted Lung Health Check (TLHC) Pilot service (ended September 2024 and currently under evaluation with NHSE)

Targeted Lung Heath Check (TLHC) Pilot Service- Currently only live in certain areas (Brighton and Hove, Hastings & St Leonards)

  • The Targeted Lung Health Check service invites patients via letter aged 55-74 registered with their GP to discuss their lung health
  • The TLHC team state a time and date they will phone the patient and ask them questions about their lifestyle, if required the patient will be invited for a lung scan to check for early signs of lung cancer at a designated van
  • If the patient is a smoker, they will be referred directly to a community pharmacy registered to participate in this pilot service
  • This service has been designed to enable NHS TLHC screening services to send an electronic referral to a community pharmacy of their choice to initiate or continue their smoking cessation treatment, including providing medication and support as required.
  • The ambition is for referral to community pharmacy to create additional capacity in the smoking cessation pathway.
  • Referrals will come from the InHealth team delivering the low dose CT scans
  • Consenting patients will be referred
  • All practices in PCN are aware that this is the route for patients to access smoking cessation
  • The service moves through PCNs on a surgery-by-surgery basis as directed within the Pilot 
  • Aligned with prevention services (including other Pharmacy Integration Pilots)
  • Very similar model to the Advanced SCS National service. There is a designated electronic referral route and a designated email address to return the patient outcome data 

Brighton & Hove

Please view the Brighton Launch webinar here.

Please view the Brighton Launch slides here

Hastings & St Leonards

Please view the Hastings & St Leonards Launch webinar here.

Please view the Hastings & St Leonards Launch slides here.

Please contact LPC@communitypharmacyss.co.uk if you would like more information or are a pharmacy that is participating and need support.


Independent Prescriber Pathfinder Pilot Service

The aim of this national pilot is to identify services a Community Pharmacy independent prescriber could deliver  in the local area working in collaboration with GPs to support patients to access services. In Sussex we have the HRT review service and in Surrey the Hypertension management service

Surrey

IP Pathfinder in Surrey will enable the Independent Prescribing Pharmacists at our Pathfinder Sites (Kents Pharmacy, and Victoria Chemist) to take on ongoing reviews and prescribing for hypertension patients referred from their partnering GP surgeries.

This aims to reduce GP appointments needed for hypertension reviews – redirecting these to Community Pharmacy. Therefore, patients can both attend their local pathfinder site (participating community pharmacy) for their blood pressure review and, if they choose to, have their medication (changed or unchanged) dispensed and collected then and there. Pathfinder sites will be using CLEO EPS for prescribing.

Eligible patients are 18 years or older, with a diagnosis of hypertension, and registered at the partnering GP surgery. They fall into 4 cohorts of patients:

  • Newly diagnosed hypertension that need hypertension medication initiated
  • Patients who need their hypertension medication up titrated
  • Patients who need their hypertension medication reduced
  • Patients who need their hypertension medication stopped (e.g. in the case of adverse drug reactions)’

We have created the below resources to support our pathfinder sites

Resources:

Final Surrey IP Pathfinder – Pre Go-live


Sussex

IP Pathfinder in Sussex will enable the Independent Prescribing Pharmacists at our Pathfinder Sites (H A Baker in Lewes and Day Lewes Arlington Road Pharmacy in Eastbourne) to take on ongoing reviews and prescribing for hormone replacement therapy (HRT) patients referred from their partnering GP surgeries.

This aims to reduce GP appointments needed for HRT reviews – redirecting these to Community Pharmacy. Therefore, patients can both attend their local pathfinder site (participating community pharmacy) for their HRT review and, if they choose to, have their medication (changed or unchanged) dispensed and collected then and there. Pathfinder sites will be using CLEO EPS for prescribing.

For this initiative, the cohort of patients are defined as those women aged 45 and over receiving a repeat prescription of oral or transdermal hormone replacement therapy (HRT), registered at the partnering GP surgery.